OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Improving these processes involves adjusting various parameters, including cell line engineering, media composition, and bioreactor conditions. A key goal is to amplify antibody titer while minimizing production expense